The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
Tomioka, Nobumoto, Azuma, Manabu, Ikarashi, Mayuko, Yamamoto, Mitsugu, Sato, Masako, Watanabe, Ken-ichi, Yamashiro, Katsushige, Takahashi, MasatoМова:
english
Журнал:
Breast Cancer
DOI:
10.1007/s12282-017-0781-0
Date:
May, 2017
Файл:
PDF, 1.24 MB
english, 2017
File converter
Більше результатів пошуку
More benefits 
